On May 8, 2013, TrialReach announced $3.1M in funding, led by Octopus Investments. The Next Web covered the exciting announcement:
"TrialReach is designed to help medical research firms recruit participants for trials. Unlike other medical trial directories that tend to rely on potential candidates going out and looking for them, the startup uses proprietary algorithms, a network of distribution partners, and tracking tools to seek out the most relevant audience for any particular trial. For example, a trial may be promoted via search engines, forums or online patient communities."
Read more on The Next Web.
